Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Some people with chronic hair loss may have thyroid autoimmunity.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Adalimumab improved folliculitis decalvans in most patients.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Mitochondrial stress can lead to atopic dermatitis.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

A(1-7) treatment reduces symptoms of lupus in mice.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Women with congenital adrenal hyperplasia showed no prostatic growth.

People with alopecia areata often have thyroid autoimmunity.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Higher DHEAS levels may cause hair loss in women by disrupting hair growth.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Hair loss in two ferrets was caused by ovarian tissue tumors, not adrenal issues.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.